Skip to main content Skip to main content
Go to homepage

Follow-Up Study Of Tofacitinib For Treatment Of Juvenile Idiopathic Arthritis (JIA)

Follow-Up Study Of Tofacitinib For Treatment Of Juvenile Idiopathic Arthritis (JIA)

Description:

Please visit clinicaltrials.gov for complete study information.

Study Status:
Closed
IRB Study ID:
160109
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.